Success Success Story Dyax Gains a Foundation for Multichannel Customer Engagement in the Cloud The Customer Dyax Corporation’s mission is to discover, develop, and commer- cialize innovative biopharmaceuticals for unmet medical needs, with an emphasis on inflammatory indications. The Massachu - setts-based biopharmaceutical company utilizes its proprietary drug discovery technology, phage display, to identify antibody, small protein, and peptide compounds for clinical development. Dyax also leverages this technology broadly with over 70 licenses and collaborations for therapeutic discovery, as well as in non- core areas such as affinity separations, diagnostic imaging, and research reagents. Across all areas, Dyax’s work is driven by one unifying factor: the needs of patients. T

Join for free to read